The total net revenues of AbbVie's Rinvoq and Skyrizi were about $25.87 billion in 2025, up 46.2% from 2024. Read why ABBV ...
Cory Fortier was just nine, when he was diagnosed with uveitis, an often painful form of arthritis of the eye.